Clinical Trials on Hematological Malignancy in United States
Total 10343 results
-
Century Therapeutics, Inc.RecruitingHematological Malignancy | Solid Tumor MalignancyUnited States
-
University of Missouri-ColumbiaRecruiting
-
M.D. Anderson Cancer CenterRecruiting
-
Henry Ford Health SystemRecruitingHematological MalignancyUnited States
-
Washington University School of MedicineBarnes-Jewish HospitalTerminatedHematological MalignancyUnited States
-
Inova Health Care ServicesRecruitingSolid Tumor | Hematological MalignancyUnited States
-
Spectrum Pharmaceuticals, IncOnxeoCompletedSolid Tumor | Hematological MalignancyUnited States
-
Fate TherapeuticsTerminatedHematological MalignancyUnited States
-
Beckman Coulter, Inc.Completed
-
Wake Forest University Health SciencesNational Cancer Institute (NCI)RecruitingHematologic MalignancyUnited States
-
NYU Langone HealthWithdrawnCancer | Hematological MalignancyUnited States
-
St. Jude Children's Research HospitalRecruitingHematologic Malignancy | Myeloid MalignancyUnited States
-
West Virginia UniversityRecruitingNeutropenia | Hematological MalignancyUnited States
-
Astellas Pharma Global Development, Inc.Basilea Pharmaceutica International LtdCompletedHematological MalignancyUnited States
-
Constellation PharmaceuticalsCompletedSolid Tumor | Advanced Malignancies | Hematological MalignancySpain, United States, Georgia
-
SanofiCompletedHematological MalignancyGreece, Spain, Peru, Israel, United States, Argentina, Belgium, Brazil, Chile, Finland, France, Italy, Mexico, Russian Federation, Turkey, Ukraine, United Kingdom
-
West Virginia UniversityCompletedHematological Malignancy | Pharmacokinetics of AcyclovirUnited States
-
Spectrum Health HospitalsMillennium Pharmaceuticals, Inc.CompletedHematological MalignancyUnited States
-
University of ChicagoStand Up To CancerRecruitingCancer | Malignant Neoplasm | MalignancyUnited States
-
Aaron Cumpston, PharmD, BCOPCompletedNeutropenia | Hematological MalignancyUnited States
-
Cancer Research UKRoyal Marsden NHS Foundation Trust; Hoffmann-La Roche; University of Manchester; University of BirminghamRecruitingGlioma | Melanoma | Neoplasms by Histologic Type | Lymphoproliferative Disorders | Neoplasms by Site | Cancer | Brain Neoplasms | Solid Tumor | Malignant Neoplasm | Malignancy | Haematological MalignancyUnited Kingdom
-
Baylor College of MedicineThe Methodist Hospital Research Institute; Center for Cell and Gene Therapy...CompletedHematologic MalignancyUnited States
-
Nottingham University Hospitals NHS TrustNewcastle University; University of Kansas; Macmillan Cancer Support; Bishop Grosseteste...TerminatedCancer | Oncologic Disorders | Nutrition Aspect of Cancer | Haematological MalignancyUnited Kingdom
-
St. Jude Children's Research HospitalRecruitingRefractory Hematologic Malignancy | Relapsed Hematologic MalignancyUnited States
-
Cancer Research UKRoyal Marsden NHS Foundation Trust; Hoffmann-La Roche; University of Manchester; University of BirminghamRecruitingSolid Tumor | Haematological MalignancyUnited Kingdom
-
CelgeneCompletedHematologic Malignancy | Malignant LymphomaUnited States, United Kingdom
-
CelgeneCompletedHematologic Malignancy | Malignant LymphomaUnited States, United Kingdom
-
Scripps Translational Science InstituteCompleted
-
The Christie NHS Foundation TrustRecruitingCOVID | Oncology | Haematological MalignancyUnited Kingdom
-
ExCellThera inc.Fred Hutchinson Cancer CenterActive, not recruitingHigh Risk Hematological Malignancy | Cord Blood TransplantUnited States, Netherlands
-
Epizyme, Inc.WithdrawnRefractory Hematologic Malignancy | Relapsed Hematologic MalignancyUnited States
-
Guardant Health, Inc.CompletedNon-Hematologic MalignancyUnited States
-
Hangzhou Sumgen Biotech Co., Ltd.RecruitingSG2501 Safety Study in Subjects With Relapsed or Refractory Hematological Malignancies and Lymphoma.Lymphoma | Hematological MalignancyUnited States
-
Joaquina BarandaActive, not recruitingAcute Myeloid Leukemia | Myelodysplastic Syndromes | Cancer | Solid Tumor | Malignant Disease | Relapsed Hematologic MalignancyUnited States
-
CRISPR Therapeutics AGEnrolling by invitationHematologic Malignancy | Solid MalignancyUnited States
-
Millennium Pharmaceuticals, Inc.Completed
-
M.D. Anderson Cancer CenterActive, not recruitingHematopoietic and Lymphoid Cell Neoplasm | Advanced Malignant Solid Neoplasm | Locally Advanced Malignant Solid Neoplasm | Recurrent Malignant Solid Neoplasm | Metastatic Malignant Solid Neoplasm | COVID-19 Infection | Recurrent Hematologic MalignancyUnited States
-
Brigham and Women's HospitalDana-Farber Cancer Institute; Robert Wood Johnson Foundation; American Society...RecruitingHematologic MalignancyUnited States
-
Prolacta BioscienceRecruiting
-
Dana-Farber Cancer InstituteRecruiting
-
Northside Hospital, Inc.RecruitingHematologic MalignancyUnited States
-
Sidney Kimmel Cancer Center at Thomas Jefferson...CompletedHematologic MalignancyUnited States
-
Sidney Kimmel Comprehensive Cancer Center at Johns...Withdrawn
-
Memorial Sloan Kettering Cancer CenterCompletedLymphoma | Acute Myeloid Leukemia | Leukemia | Myelodysplastic Syndrome | Myeloma | Hematological MalignancyUnited States
-
Massachusetts General HospitalRecruiting
-
Abramson Cancer Center of the University of PennsylvaniaCompleted
-
NYU Langone HealthActive, not recruitingHematologic MalignancyUnited States
-
Memorial Sloan Kettering Cancer CenterCompleted
-
Garcia, Jose M., MD, PhDActive, not recruitingHematologic MalignancyUnited States
-
Massachusetts General HospitalCompleted